{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/rosacea/diagnosis/differential-diagnosis/","result":{"pageContext":{"chapter":{"id":"e111154d-c82a-5292-b201-f4a12a8a4d17","slug":"differential-diagnosis","fullItemName":"Differential diagnosis","depth":2,"htmlHeader":"<!-- begin field c84dd070-e0c8-4930-96bf-3e9840bd9c0e --><h2>What else might it be?</h2><!-- end field c84dd070-e0c8-4930-96bf-3e9840bd9c0e -->","summary":"","htmlStringContent":"<!-- begin item 9c5fd44c-7cd3-4986-9449-30483ad37431 --><!-- begin field c7601cd4-1398-4626-b1b9-6cc47edf2083 --><p><strong>Other conditions that may present similarly to rosacea include:</strong></p><ul><li>Acne vulgaris — usually features comedones, without telangiectasia, flushing, or significant erythema. It can also affect the back and chest, and typically presents in teenagers and young adults. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/acne-vulgaris/\">Acne vulgaris</a> for more information.</li><li>Seborrhoeic dermatitis — yellow greasy scales on an erythematous base, usually found on the sebum-rich areas of the scalp and face (including the ears, eyebrows, and nasolabial folds). See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/seborrhoeic-dermatitis/\">Seborrhoeic dermatitis</a> for more information<em>.</em></li><li>Contact dermatitis — eczematous itchy rash with dry skin, scaling, and possible vesicles. Often improves if the causative irritant or allergen is removed, and it may affect a person of any age. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/dermatitis-contact/\">Dermatitis - contact</a> for more information.</li><li>Photodermatitis/photodamage — general erythema in a sunlight-exposed distribution, including areas other than the face, that may present with blisters and/or scaly patches.</li><li>Peri-oral and peri-ocular dermatitis — self-limiting small red papules and pustules near the mouth, nose, and eyes, often in the absence of flushing and telangiectasia. Often in young women.</li><li>Corticosteroid-induced dermatitis — due to long-term use of topical corticosteroids, characterized by generalized redness, skin atrophy, and possible striae.</li><li>Folliculitis — a superficial infection of the hair follicles, which develop into small inflammatory papules or pustules. May occur in isolation or in association with rosacea. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/boils-carbuncles-staphylococcal-carriage/\">Boils, carbuncles, and staphylococcal carriage</a> for more information.</li><li>Systemic lupus erythematosus (SLE) — discoid or malar 'butterfly' distribution of a facial rash affecting the cheeks and nasal bridge, often associated with photosensitivity, and possible systemic involvement. Rarely presents with pustules.</li><li>Erysipelas — a bacterial infection usually caused by Group A beta-haemolytic streptococci, predominantly affecting the lower limbs. When it involves the face it can have a ‘butterfly’ distribution on the cheeks and bridge of the nose. It is characterized by red, firm, and swollen skin, which may be finely dimpled and blistered. It is usually abrupt in onset, often accompanied by fever. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/cellulitis-acute/\">Cellulitis - acute</a> for more information.</li><li>Keratosis pilaris — a common, genetic condition, characterized by distinct keratotic follicular papules without background erythema, often affecting the proximal arms.</li><li>Mastocytosis — a rare condition caused by an excess of mast cells in the body tissue, which may present as flushing, itch, abdominal pain, nausea or vomiting, musculoskeletal pain, headache, or neuropsychiatric symptoms.</li><li>Sarcoidosis — a rare granulomatous condition that typically presents as tender, translucent yellow-red papules on the skin (including the face). There may be systemic involvement.</li></ul><!-- end field c7601cd4-1398-4626-b1b9-6cc47edf2083 --><!-- end item 9c5fd44c-7cd3-4986-9449-30483ad37431 -->","topic":{"id":"907deb55-501c-50b0-9c07-5956c70cf201","topicId":"d6855039-5025-454d-b195-d4b0a3763978","topicName":"Rosacea ","slug":"rosacea","lastRevised":"Last revised in January 2021","chapters":[{"id":"a3d8bb8f-cf98-5320-abe8-71c7b0c3d604","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"a9c3b514-8e94-52d5-8de7-2caedcdd8ed3","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"efe24f29-88ad-5507-b4b5-ec00c54a404d","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"10634254-4474-5303-9337-e3682fd14514","slug":"changes","fullItemName":"Changes"},{"id":"1ad5ada5-1ed7-5223-b60c-122b20127e1e","slug":"update","fullItemName":"Update"}]},{"id":"832a95da-0571-5031-b437-3cc5568bc7fa","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"59d41997-63c3-57d4-8c29-c4655d090e7a","slug":"goals","fullItemName":"Goals"},{"id":"2c3bc0a5-be4b-5a98-a5d8-02e7cb85b9cb","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"f8c34a65-7879-5a21-87df-68739ba5d1f3","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"9f050a9b-10be-5d79-b662-0099ac611890","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"9fcdbb11-1f96-5ae9-aeec-617a9da55e12","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"538579d3-7620-5145-a70f-022ec13226ae","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d0b606da-7836-5c33-8390-23a6dad9e7bd","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"ed198aaf-1444-5590-ab74-c9fdff996b5e","slug":"definition","fullItemName":"Definition"},{"id":"df406671-3834-580f-836a-3c2428245359","slug":"prevalence","fullItemName":"Prevalence"},{"id":"be28c459-5653-506e-937c-5c4d2f7ceecd","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"bc98e144-7d7d-5fa2-97ad-7c1bd8526ca0","slug":"complications","fullItemName":"Complications"},{"id":"1a5cbcf6-2870-5a82-a207-8c8888f907d2","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"d654b61f-b47e-5123-b965-f806f0eb2e6d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"bd6d5455-d63e-5507-8bdd-028b338047cc","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"30d3265f-84ec-5ac7-a410-bc11cd078ac9","slug":"assessment","fullItemName":"Assessment"},{"id":"e111154d-c82a-5292-b201-f4a12a8a4d17","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"e753e991-54fe-5ab5-96d2-124372f1292f","fullItemName":"Management","slug":"management","subChapters":[{"id":"0e7b3ebf-33f5-5b51-a9ab-81c8dda1332f","slug":"rosacea","fullItemName":"Scenario: Rosacea"}]},{"id":"602c95a0-f64e-593e-85c4-798ea728733b","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"e6e7bc13-b6bd-5b5e-b337-196c3291ee63","slug":"topical-treatments","fullItemName":"Topical treatments"},{"id":"c53198f5-f60b-5fb6-8767-9f9a275329f5","slug":"oral-antibiotics","fullItemName":"Oral antibiotics"}]},{"id":"0db34d3f-c02f-5b8f-8498-90541139bc2a","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"ca47aba9-e0da-5e0a-a1a2-46bfab6fe609","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"5c0a0103-4ed2-586f-8fbd-aaf6fe82f548","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"84966474-462f-592c-b43d-474d1ca89d52","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"bb2d8252-c981-52ba-9faf-d9e9450efe7c","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f5e586ed-912a-51ab-b246-3a6f6c67e2d1","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a60f4af9-1a6a-5a71-9310-2b3fe7d0cb92","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"40a50d91-c85e-5b2c-b283-ca2a9f30c6f0","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"d654b61f-b47e-5123-b965-f806f0eb2e6d","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"0c8e6d2e-92ed-5116-b517-aecf8c2345c1","slug":"basis-for-recommendation-943","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field b8c30103-c0ef-428f-b761-48ab13042547 --><h3>Basis for recommendation</h3><!-- end field b8c30103-c0ef-428f-b761-48ab13042547 -->","summary":null,"htmlStringContent":"<!-- begin item 943b6fd0-a7c4-4117-8083-3625e3796fc6 --><!-- begin field 41051895-12d6-4958-8c3e-7dde5c8baaba --><p>The information on differential diagnoses of rosacea is based on the US National Rosacea Society (NRS) expert committee publication <em>Standard classification and pathophysiology of rosacea</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rosacea/references/\">Gallo, 2018</a>], the ROSacea COnsensus (ROSCO) international consensus publication <em>Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rosacea/references/\">Tan, 2017</a>], the American Acne and Rosacea Society (AARS) publication <em>Update on the management of rosacea from the American Acne and Rosacea Society (AARS)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rosacea/references/\">Del Rosso, 2019</a>], and expert opinion in review articles on rosacea [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rosacea/references/\">Culp, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rosacea/references/\">Oge, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rosacea/references/\">van Zuuren, 2017</a>] and on the epidemiology of rosacea [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rosacea/references/\">Alexis, 2019</a>].</p><!-- end field 41051895-12d6-4958-8c3e-7dde5c8baaba --><!-- end item 943b6fd0-a7c4-4117-8083-3625e3796fc6 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}